Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Tan Sheet

Executive Summary

Vitamin Shoppe buys Super Supplements; investor Ackman wages war on Herbalife; NPA cancels MarketPlace show; Herbalife acquires N.C. facility; Capsugel expands quality control; AHP releases aloe vera monograph standard: more news In Brief.

You may also be interested in...



Herbalife Sales, Distributor Data Contradict Pyramid Scheme Allegation, Executives Say

Despite regulatory investigations spurred by activist investor Bill Ackman, Herbalife reported its 18th consecutive earnings period of record sales, executives with the direct seller say. First-quarter global sales increased 12.4% to $1.3 billion with growth in five of its six regions.

Herbalife Sales, Distributor Data Contradict Pyramid Scheme Allegation, Executives Say

Despite regulatory investigations spurred by activist investor Bill Ackman, Herbalife reported its 18th consecutive earnings period of record sales, executives with the direct seller say. First-quarter global sales increased 12.4% to $1.3 billion with growth in five of its six regions.

Sales & Earnings In Brief: Church & Dwight, Vitamin Shoppe, DSM

Gummy up, organic flat for Church & Dwight; Vitamin Shoppe expands private label; fish oil prices hit DSM’s nutrition sales; Vitacost grows sales, trims costs; more Sales & Earnings In Brief.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS106152

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel